EMEA-001868-PIP02-16 - paediatric investigation plan
5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridi-2-yl)-4-methylbenzamide
PIPHuman
Gilead Sciences International Ltd.
United Kingdom
E-mail: regulatory.pip@gilead.com
Tel.: +44 1223897300
Fax: +44 (0)1223897284